Position in LLY
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$8,958,543
+$2,206,512 QoQ
Shares Held
7,469
+1.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.92%
of 13F equity value
Holder Rank
#1,319
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ROMAN BUTLER FULLERTON & CO holds $17,219,272 across 8 Drug Manufacturers - General names. LLY ranks #1 (52.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
7,469 | $8,958,543 | |
| 2 | JNJ |
Johnson & Johnson
|
11,481 | $2,915,829 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
27,189 | $1,566,630 | |
| 4 | MRK |
Merck & Co., Inc.
|
8,695 | $1,117,307 | |
| 5 | ABBV |
AbbVie Inc.
|
4,372 | $1,100,170 | |
| 6 | AMGN |
Amgen Inc
|
1,956 | $708,306 | |
| 7 | PFE |
Pfizer Inc
|
23,293 | $560,895 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,308 | $291,592 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,958,543 | 7,469 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $6,752,031 | 7,341 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $7,853,762 | 7,308 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $5,472,999 | 7,173 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $6,994,722 | 8,973 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $7,205,238 | 8,724 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $7,487,628 | 9,699 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $8,883,320 | 10,027 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $8,967,788 | 9,905 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $7,655,904 | 9,841 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $5,705,620 | 9,788 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $5,353,037 | 9,966 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $4,634,460 | 9,882 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $3,203,421 | 9,328 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $3,949,974 | 10,797 | Shares | Sole | 2023-01-23 | |
| 2022-09-30 | $3,494,766 | 10,808 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $4,105,076 | 12,661 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $2,241,704 | 7,828 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $917,326 | 3,321 | Shares | Sole | 2022-01-24 | |
| 2021-09-30 | $767,086 | 3,320 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $767,285 | 3,343 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $624,165 | 3,341 | Shares | Sole | 2021-04-22 | |
| 2020-12-31 | $489,298 | 2,898 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $395,509 | 2,672 | Shares | Sole | 2020-10-15 | |
| 2020-06-30 | $438,360 | 2,670 | Shares | Sole | 2020-07-28 | |
| 2020-03-31 | $370,243 | 2,669 | Shares | Sole | 2020-04-13 | |
| No filing history on record for this holder in this stock. | ||||||